REQUEST A DEMO
Total
USD $0.00
Search more companies

Phoenix Pharma S.A.S. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Phoenix Pharma S.A.S. Profile Updated: June 16, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Phoenix Pharma S.A.S. is a company in Ecuador, with a head office in Daule. The enterprise operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. Phoenix Pharma S.A.S. was incorporated on February 21, 2022. 4 (2024) employees currently work for Phoenix Pharma S.A.S.. From the latest financial highlights, Phoenix Pharma S.A.S. reported a net sales revenue drop of 39.25% in 2024. During that time, Phoenix Pharma S.A.S.’s total assets grew by 49.36%. The net profit margin of Phoenix Pharma S.A.S. decreased by 37.7% in 2024.

Headquarters
Via Daule, Solar 15
Daule; Guayas;

Contact Details: Purchase the Phoenix Pharma S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Phoenix Pharma S.A.S. report to view the information.
Registered Capital:
Purchase the Phoenix Pharma S.A.S. report to view the information.
Financial Auditors:
Purchase the Phoenix Pharma S.A.S. report to view the information.
Incorporation Date:
February 21, 2022
Key Executives
Purchase this report to view the information.
General Manager
Company Performance
Financial values in the chart are available after Phoenix Pharma S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-39.25%
Total operating revenue
-39.25%
Operating profit (EBIT)
-63.01%
EBITDA
-63.01%
Net Profit (Loss) for the Period
-63.01%
Total Assets
49.36%
Total Equity
40.54%
Operating Profit Margin (ROS)
-37.7%
Net Profit Margin
-37.7%
Return on Equity (ROE)
-80.74%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?